LFMD · LifeMD, Inc.
Market Cap
$165.81M
Shares
48.20M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.20
Open$3.24
Day$3.20–3.36
52W close$2.64–6.97
Avg vol 30d951K
Short int7.2M · 15.0% float · 14.8d
Short vol70%
Last earningsAug 5, 2026
DataJan 2020–Sep 2026
Filing10-Q · Aug 5
Up next
Next earnings call
Nov 11, 2026
Est · unconfirmed
· in 8 wks
filed Aug 5, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$191.59M
Trailing 12 months
Net income (TTM)
−$330,834
Trailing 12 months
Revenue growth YoY
-3.5%
Year over year
Operating margin
-10.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-6.7%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+7.6%
Year over year · more shares
Price change (1Y)
-46.6%
Trailing year
Short interest
15.0%
Latest settlement · 14.8 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 15.4 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−16%
below
Price vs 50-day avg
−11%
below
RSI (14)
46
neutral
MACD trend
Positive
52-week position
13%
near low
Momentum
relative strength
1-month return
−6%
trailing
6-month return
−19%
trailing
YTD return
−6%
this year
Relative strength
−37%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+13% holders QoQ · +25 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
15.02% of float · ▲ +4.2% MoM · 14.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
116 holders — mid 3-yr range
Squeeze score
71
high risk · 0–100
Fundamentals
Revenue growth
+50%
Y/Y
Gross margin
1334%
contracting
EPS growth
+142%
Y/Y
Free cash flow
$6.4M
Quant / Vol
risk profile
Volatility
80%
annualized · 1-yr
Max drawdown
−62%
past year
ATR
6.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 5, 2026
third quarter of 2026
Revenue
Initiated
$48M – $51M
prior qtr $47.28M
midpoint +4.7% QoQ
full year 2026
Revenue
Initiated
$205.5M – $212.5M
prior FY $194.06M
midpoint +7.7% Y/Y
Prior guidance
period ended
· from the Earnings Call filed Sep 30, 2021
Full year 2021 revenue
· full year 2021
$90M – $100M
Guided vs delivered
· last 2 settled
Full year 2021 revenue
full year 2021
guided $90M – $100M
$92.88M
In line
Full-year 2020 revenue
full-year 2020
guided at least $40M
$37.29M
Miss −6.8%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−16%
Bearish
Price vs 50-day avg
−11%
Bearish
RSI (14)
46
Neutral
MACD trend
Positive
Bullish
52-week position
13%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+13% holders QoQ · +25 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
15.02% of float · ▲ +4.2% MoM · 14.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
116 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $3
Now $3 · 13%
Range high $7
vs 200-day avg -16%
vs 50-day avg -11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LFMD
this stock
LifeMD, Inc.
|
$165.81M | -6.2% | +49.8% | — | 15.0% |
|
VEEV
Veeva Systems Inc
|
$43.69B | +18.2% | +28.1% | 44.2 | 3.0% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$12.54B | -28.9% | — | — | 0.0% |
|
TEM
Tempus AI, Inc.
|
$11.99B | +36.1% | +83.4% | — | 16.3% |
|
BTSG
BrightSpring Health Services, Inc.
|
$11.73B | +51.1% | +28.2% | 35.9 | 5.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LFMD | +5.6% | -5.9% | -18.8% | +3.6% | -6.2% |
| SPY | +0.6% | -0.8% | +18.2% | -0.6% | +11.8% |
| vs SPY | +5.0% | -5.0% | -37.0% | +4.1% | -18.0% |